Legal
Filter News
Found 7,127 articles
-
And now, this
6/20/2018
There are no words to describe and acknowledge this historic moment in Canada.
-
Novartis and Michael Cohen, attorney to President Donald Trump, had a much deeper relationship than has been previously disclosed and was selling access to the White House, a new report issued by Senate Democrats alleges.
-
In a particularly large result, a St. Louis jury awarded almost $4.7 billion in total damages to 22 women and their families in a lawsuit against Johnson & Johnson.
-
Saturnino “Nino” Fanlo, chief financial officer and chief operations officer of Human Longevity (HLI), has left the company. Fanlo was implicated in a scandal at his previous employer, online lender Social Finance (SoFi).
-
Johnson & Johnson's Official Statement in Response to Today's Verdict in St. Louis Trial
7/13/2018
Johnson & Johnson (NYSE: JNJ) issued the following statement regarding today's verdict in the St. Louis court.
-
National Kidney Foundation Statement on Centers for Medicare & Medicaid Services Rule on Medicare Payments to Dialysis Facilities
7/12/2018
Yesterday evening the Centers for Medicare & Medicaid Services (CMS) issued the annual proposed rule governing Medicare payments to dialysis facilities and the quality measures for which the dialysis facilities are held accountable.
-
ACEP Applauds FDA Launch of Drug Shortage Task Force
7/12/2018
In response to the Food and Drug Administration's (FDA) formation of a new Drug Shortage Task Force as requested by Congress, the American College of Emergency Physicians (ACEP) and several other physician specialty groups, Paul Kivela, MD, FACEP, president of ACEP released the following statement
-
ECM Therapeutics, Inc. A Regenerative Medicine Company
7/12/2018
ECM Therapeutics, Inc. is a regenerative medicine company that develops and manufactures diagnostic and therapeutic products derived from a naturally occurring material called extracellular matrix (ECM).
-
Health Canada Launches Public Consultations on Proposed Approach to Cost Recovery for the Regulation of Cannabis
7/12/2018
The Cannabis Act has been passed by Parliament and will come into force on October 17, 2018.
-
Iowa Department of Public Health Awards License to Acreage Holdings
7/12/2018
Nation's Largest Cannabis Company Gains State's Second License to Manufacture Cannabis Oil
-
Qualigen in-licenses novel cancer drug from University of Louisville (UofL)
7/12/2018
New Formulation is Key to Fulfilling Promise of Prior Clinical Studies
-
Statement by FDA Commissioner Scott Gottlieb, M.D., on formation of a new drug shortages task force and FDA's efforts to advance long-term solutions to prevent shortages
7/12/2018
We've seen the number of new drug shortages steadily decline since a peak in 2011 owing to the work of the FDA, industry and other groups.
-
Therapix Biosciences Signs Term Sheet for the Transfer of Non-Pain Cannabinoid-Based Drug Pipeline Assets to Cure Pharmaceutical
7/12/2018
Therapix Biosciences Ltd. announced that it has signed a non-binding term sheet with CURE Pharmaceutical for the transfer to CURE of the non-pain assets of Therapix, subject to the fulfillment of the certain conditions.
-
Mesothelioma Victims Center Extends Services to a Railroad Conductor or Engineer with Mesothelioma- Call for On-The-Spot Access To The Nation's Best Lawyers For Better Compensation Results
7/12/2018
The Mesothelioma Victims Center is appealing to a railroad conductor or engineer who has recently been diagnosed with mesothelioma to call them anytime at 800-714-0303 to ensure on-the-spot access to some of the nation's most experienced mesothelioma lawyers who consistently get the best possible financial compensation results for their clients.
-
McKesson Applauds DOJ Policy Change on Opioid Quotas
7/12/2018
Company previously called for revisions to production quota
-
FDA expands its support for states to advance implementation of produce safety activities
7/12/2018
The U.S. Food and Drug Administration announced new cooperative agreements with Hawaii, Kentucky and Mississippi, as well as renewed agreements with 43 other states, in support of efforts to implement the FDA Food Safety Modernization Act (FSMA) Produce Safety Rule
-
Arcus Biosciences Announces That Taiho Pharmaceutical Has Exercised Its Option to Develop and Commercialize AB928 in Its Territories
7/12/2018
Arcus Biosciences, Inc. announced that Taiho Pharmaceutical Co., Ltd. exercised its option under the Option and License Agreement entered into in September 2017 (Taiho Agreement) to obtain an exclusive development and commercialization license to the Company’s adenosine receptor antagonist program
-
B.C. Pharmacists Able to Make Substitution for Patients During Drug Recall
7/12/2018
More than 30,000 British Columbians have been impacted by Health Canada’s July 9 recall of valsartan, a generic cardiovascular drug, because of concerns around an impurity in the drug.
-
Whistleblower Complaint, Investigation Demands and Claimed Breaches of Fiduciary Duty Are Part of...
7/11/2018
The lawsuit and counter-lawsuits over the ouster of Rockwell Medical’s chief executive officer can be convoluted to follow, particularly as allegations are thrown around. BioSpace has put together a synopsis of the events. -
Schultz Chan, the former director of biostatistics at Cambridge-based Akebia Therapeutics and Songjiang Wang, a director of statistical programming at Merrimack Pharmaceuticals (MACK) were convicted of insider trading by a federal grand jury in Boston.